AZD9164 Single Ascending Dose Study in Healthy Male Subjects
NCT00847249
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AZD9164
DRUG:
Placebo
Sponsor
AstraZeneca